|
1
|
Bray F, Ferlay J, Soerjomataram I, Siegel
RL, Torre LA and Jemal A: Global cancer statistics 2018: GLOBOCAN
estimates of incidence and mortality worldwide for 36 cancers in
185 countries. CA Cancer J Clin. 68:394–424. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Obeid R and Pietrzik K: Smoking, B
vitamins, and lung cancer: The chicken or the egg causality
dilemma. J Clin Oncol. 36:626–627. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Seitz H and Poschl G: Alcohol and
gastrointestinal cancer: Pathogenic mechanisms. Addict Biol.
2:19–33. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Aghilinejad M, Kabir-Mokamelkhah E,
Imanizade Z and Danesh H: Occupational class groups as a risk
factor for gastrointestinal cancer: A case-control study. Int J
Occup Environ Med. 8:21–31. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
He J, Li Y, Cao Y, Xue J and Zhou X: The
oral microbiome diversity and its relation to human diseases. Folia
Microbiol (Praha). 60:69–80. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Costello EK, Lauber CL, Hamady M, Fierer
N, Gordon JI and Knight R: Bacterial community variation in human
body habitats across space and time. Science. 326:1694–1697. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Ahn J, Chen CY and Hayes RB: Oral
microbiome and oral and gastrointestinal cancer risk. Cancer Causes
Control. 23:399–404. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Zhang Y, Niu Q, Fan W, Huang F and He H:
Oral microbiota and gastrointestinal cancer. Onco Targets Ther.
12:4721–4728. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Karpinski TM: Role of oral microbiota in
cancer development. Microorganisms. 7:202019. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Yang L, Zheng R, Wang N, Yuan Y, Liu S, Li
H, Zhang S, Zeng H and Chen W: Incidence and mortality of stomach
cancer in China, 2014. Chin J Cancer Res. 30:291–298. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Bhaskar KR, Garik P, Turner BS, Bradley
JD, Bansil R, Stanley HE and LaMont JT: Viscous fingering of HCl
through gastric mucin. Nature. 360:458–461. 1992. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Bik EM, Eckburg PB, Gill SR, Nelson KE,
Purdom EA, Francois F, Perez-Perez G, Blaser MJ and Relman DA:
Molecular analysis of the bacterial microbiota in the human
stomach. Proc Natl Acad Sci USA. 103:732–737. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Theisen J, Nehra D, Citron D, Johansson J,
Hagen JA, Crookes PF, DeMeester SR, Bremner CG, DeMeester TR and
Peters JH: Suppression of gastric acid secretion in patients with
gastroesophageal reflux disease results in gastric bacterial
overgrowth and deconjugation of bile acids. J Gastrointest Surg.
4:50–54. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Hunt RH, Camilleri M, Crowe SE, El-Omar
EM, Fox JG, Kuipers EJ, Malfertheiner P, McColl KE, Pritchard DM,
Rugge M, et al: The stomach in health and disease. Gut.
64:1650–1668. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Maffei HV and Nóbrega FJ: Gastric pH and
microflora of normal and diarrhoeic infants. Gut. 16:719–726. 1975.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Ijyuuin T and Umehara F: Case of
Streptococcus salivarius bacteremia/meningoencephalitis
leading to discovery of early gastric cancer. Rinsho Shinkeigaku.
52:360–363. 2012.(In Japanese). View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Yamamura K, Baba Y, Miyake K, Nakamura K,
Shigaki H, Mima K, Kurashige J, Ishimoto T, Iwatsuki M, Sakamoto Y,
et al: Fusobacterium nucleatum in gastroenterological
cancer: Evaluation of measurement methods using quantitative
polymerase chain reaction and a literature review. Oncol Lett.
14:6373–6378. 2017.PubMed/NCBI
|
|
18
|
Shao DT and Wei WW: Progress in research
of human microbiota for upper gastrointestinal tumors and
precancerous lesions. Zhonghua Liu Xing Bing Xue Za Zhi.
39:382–386. 2018.(In Chinese). PubMed/NCBI
|
|
19
|
Sun JH, Li XL, Yin J, Li YH, Hou BX and
Zhang Z: A screening method for gastric cancer by oral microbiome
detection. Oncol Rep. 39:2217–2224. 2018.PubMed/NCBI
|
|
20
|
Wu J, Xu S, Xiang C, Cao Q, Li Q, Huang J,
Shi L, Zhang J and Zhan Z: Tongue coating microbiota community and
risk effect on gastric cancer. J Cancer. 9:4039–4048. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Sun J, Zhou M, Salazar CR, Hays R, Bedi S,
Chen Y and Li Y: Chronic periodontal disease, periodontal pathogen
colonization, and increased risk of precancerous gastric lesions. J
Periodontol. 88:1124–1134. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Van Cutsem E, Sagaert X, Topal B,
Haustermans K and Prenen H: Gastric cancer. Lancet. 388:2654–2664.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Chen W, Zheng R, Zeng H, Zhang S and He J:
Annual report on status of cancer in China, 2011. Chin J Cancer
Res. 27:2–12. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Klingelhofer D, Zhu Y, Braun M, Bruggmann
D, Schoffel N and Groneberg DA: A world map of esophagus cancer
research: A critical accounting. J Transl Med. 17:1502019.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Wang LD, Shi ST, Zhou Q, Goldstein S, Hong
JY, Shao P, Qiu SL and Yang CS: Changes in p53 and cyclin D1
protein levels and cell proliferation in different stages of human
esophageal and gastric-cardia carcinogenesis. Int J Cancer.
59:514–519. 1994. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Lin Y, Totsuka Y, Shan B, Wang C, Wei W,
Qiao Y, Kikuchi S, Inoue M, Tanaka H and He Y: Esophageal cancer in
high-risk areas of China: Research progress and challenges. Ann
Epidemiol. 27:215–221. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Zhou YC, Chen TT and Chen XD: Trend
analysis in incidence rates of digestive system cancers in Taixing,
2006–2010. Chin J Prev Contr Chron Dis. 20:635–637. 2012.(In
Chinese).
|
|
28
|
Enzinger PC and Mayer RJ: Esophageal
cancer. N Engl J Med. 349:2241–2252. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Burki TK: Mutational subgroups for
oesophageal adenocarcinoma. Lancet Oncol. 17:e4262016. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Yang X, Ni Y, Yuan Z, Chen H, Plymoth A,
Jin L, Chen X, Lu M and Ye W: Very hot tea drinking increases
esophageal squamous cell carcinoma risk in a high-risk area of
China: A population-based case-control study. Clin Epidemiol.
10:1307–1320. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Yang X, Chen X, Zhuang M, Yuan Z, Nie S,
Lu M, Jin L and Ye W: Smoking and alcohol drinking in relation to
the risk of esophageal squamous cell carcinoma: A population-based
case-control study in China. Sci Rep. 7:172492017. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Suo C, Yang Y, Yuan Z, Zhang T, Yang X,
Qing T, Gao P, Shi L, Fan M, Cheng H, et al: Alcohol intake
interacts with functional genetic polymorphisms of aldehyde
dehydrogenase (ALDH2) and alcohol dehydrogenase (ADH) to increase
esophageal squamous cell cancer risk. J Thorac Oncol. 14:712–725.
2019. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Yu Z, Li XM, Huai M, Lu GJ, Wang C, Wang
QY and Liu QY: Clinic features and prognostic analysis for T1
esophagus cancer. Zhonghua Zhong Liu Za Zhi. 40:268–273. 2018.(In
Chinese). PubMed/NCBI
|
|
34
|
Li H, Jiang C, Wu D, Shi S, Liao M, Wang
J, Li Y and Xu Z: The prognostic and clinicopathologic
characteristics of CD147 and esophagus cancer: A meta-analysis.
PLoS One. 12:e01802712017. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Peters BA, Wu J, Pei Z, Yang L, Purdue MP,
Freedman ND, Jacobs EJ, Gapstur SM, Hayes RB and Ahn J: Oral
microbiome composition reflects prospective risk for esophageal
cancers. Cancer Res. 77:6777–6787. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Halec G, Schmitt M, Egger S, Abnet CC,
Babb C, Dawsey SM, Flechtenmacher C, Gheit T, Hale M, Holzinger D,
et al: Mucosal alpha-papillomaviruses are not associated with
esophageal squamous cell carcinomas: Lack of mechanistic evidence
from South Africa, China and Iran and from a world-wide
meta-analysis. Int J Cancer. 139:85–98. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Narikiyo M, Tanabe C, Yamada Y, Igaki H,
Tachimori Y, Kato H, Muto M, Montesano R, Sakamoto H, Nakajima Y
and Sasaki H: Frequent and preferential infection of Treponema
denticola, Streptococcus mitis, and Streptococcus
anginosus in esophageal cancers. Cancer Sci. 95:569–574. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Chen X, Winckler B, Lu M, Cheng H, Yuan Z,
Yang Y, Jin L and Ye W: Oral microbiota and risk for esophageal
squamous cell carcinoma in a high-risk area of China. PLoS One.
10:e01436032015. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Domingues-Ferreira M, Grumach AS, Duarte
AJ and De Moraes-Vasconcelos D: Esophageal cancer associated with
chronic mucocutaneous candidiasis. Could chronic candidiasis lead
to esophageal cancer? Med Mycol. 47:201–205. 2009.PubMed/NCBI
|
|
40
|
Bonavina L, Incarbone R, Reitano M,
Tortorano A, Viviani M and Peracchia A: Candida colonization in
patients with esophageal disease: A prospective clinical study. Dis
Esophagus. 16:70–72. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Tanda N, Washio J, Kamei T, Akazawa K,
Takahashi N and Koseki T: Professional oral care reduces
carcinogenic acetaldehyde levels in mouth air of perioperative
esophageal cancer patients: A prospective comparative study. Tohoku
J Exp Med. 249:75–83. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Nishino T, Takizawa H, Yoshida T, Inui T,
Takasugi H, Matsumoto D, Kawakita N, Inoue S, Sakiyama S, Tangoku
A, et al: Current status and effectiveness of perioperative oral
health care management for lung cancer and esophageal cancer
patients. Kyobu Geka. 69:30–34. 2016.(In Japanese). PubMed/NCBI
|
|
43
|
Tirelli G, Gatto A, Boscolo Nata F,
Bussani R, Piccinato A, Marcuzzo AV and Tofanelli M: Prognosis of
oral cancer: A comparison of the staging systems given in the 7 and
8th editions of the American joint committee on cancer staging
manual. Br J Oral Maxillofac Surg. 56:8–13. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Kujan O, Glenny AM, Duxbury J, Thakker N
and Sloan P: Evaluation of screening strategies for improving oral
cancer mortality: A Cochrane systematic review. J Dent Educ.
69:255–265. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Kunkler I: Treatment of oral cancer.
Radiotherapy may be as effective as surgery. BMJ. 319:7061999.
View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Patil VM, Noronha V, Joshi A, Dhumal S,
Mahimkar M, Bhattacharjee A, Gota V, Pandey M, Menon N, Mahajan A,
et al: Phase I/II study of palliative triple metronomic
chemotherapy in platinum-refractory/early-failure oral cancer. J
Clin Oncol. 37:3032–3041. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Yang JS, Wu CC, Lee HZ, Hsieh WT, Tang FY,
Bau DT, Lai KC, Lien JC and Chung JG: Suppression of the TNF-alpha
level is mediated by Gan-Lu-Yin (traditional Chinese medicine) in
human oral cancer cells through the NF-kappa B, AKT, and
ERK-dependent pathways. Environ Toxicol. 31:1196–1205. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Lee HC, Liang A, Lin YH, Guo YR and Huang
SY: Low dietary n-6/n-3 polyunsaturated fatty acid ratio prevents
induced oral carcinoma in a hamster pouch model. Prostaglandins
Leukot Essent Fatty Acids. 136:67–75. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Takahashi Y, Park J, Hosomi K, Yamada T,
Kobayashi A, Yamaguchi Y, Iketani S, Kunisawa J, Mizuguchi K, Maeda
N and Ohshima T: Analysis of oral microbiota in Japanese oral
cancer patients using 16S rRNA sequencing. J Oral Biosci.
61:120–128. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Schmidt BL, Kuczynski J, Bhattacharya A,
Huey B, Corby PM, Queiroz EL, Nightingale K, Kerr AR, DeLacure MD,
Veeramachaneni R, et al: Changes in abundance of oral microbiota
associated with oral cancer. PLoS One. 9:e987412014. View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Zhao H, Chu M, Huang Z, Yang X, Ran S, Hu
B, Zhang C and Liang J: Variations in oral microbiota associated
with oral cancer. Sci Rep. 7:117732017. View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Guerrero-Preston R, Godoy-Vitorino F,
Jedlicka A, Rodríguez-Hilario A, González H, Bondy J, Lawson F,
Folawiyo O, Michailidi C, Dziedzic A, et al: 16S rRNA amplicon
sequencing identifies microbiota associated with oral cancer, human
papilloma virus infection and surgical treatment. Oncotarget.
7:51320–51334. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
53
|
Lee WH, Chen HM, Yang SF, Liang C, Peng
CY, Lin FM, Tsai LL, Wu BC, Hsin CH, Chuang CY, et al: Bacterial
alterations in salivary microbiota and their association in oral
cancer. Sci Rep. 7:165402017. View Article : Google Scholar : PubMed/NCBI
|
|
54
|
Perera M, Al-Hebshi NN, Perera I, Ipe D,
Ulett GC, Speicher DJ, Chen T and Johnson NW: Inflammatory
bacteriome and oral squamous cell carcinoma. J Dent Res.
97:725–732. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
55
|
Yost S, Stashenko P, Choi Y, Kukuruzinska
M, Genco CA, Salama A, Weinberg EO, Kramer CD and Frias-Lopez J:
Increased virulence of the oral microbiome in oral squamous cell
carcinoma revealed by metatranscriptome analyses. Int J Oral Sci.
10:322018. View Article : Google Scholar : PubMed/NCBI
|
|
56
|
Hsiao JR, Chang CC, Lee WT, Huang CC, Ou
CY, Tsai ST, Chen KC, Huang JS, Wong TY, Lai YH, et al: The
interplay between oral microbiome, lifestyle factors and genetic
polymorphisms in the risk of oral squamous cell carcinoma.
Carcinogenesis. 39:778–787. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
57
|
Wu JS, Zheng M, Zhang M, Pang X, Li L,
Wang SS, Yang X, Wu JB, Tang YJ, Tang YL and Liang XH:
Porphyromonas gingivalis promotes
4-nitroquinoline-1-oxide-induced oral carcinogenesis with an
alteration of fatty acid metabolism. Front Microbiol. 9:20812018.
View Article : Google Scholar : PubMed/NCBI
|
|
58
|
Gonzalez-Ramirez I, Irigoyen-Camacho ME,
Ramirez-Amador V, Lizano-Soberón M, Carrillo-García A,
García-Carrancá A, Sánchez-Pérez Y, Méndez-Martínez R,
Granados-García M, Ruíz-Godoy L and García-Cuellar C: Association
between age and high-risk human papilloma virus in Mexican oral
cancer patients. Oral Dis. 19:796–804. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
59
|
Nagy KN, Sonkodi I, Szöke I, Nagy E and
Newman HN: The microflora associated with human oral carcinomas.
Oral Oncol. 34:304–308. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
60
|
Byakodi R, Krishnappa R, Keluskar V,
Bagewadi A and Shetti A: The microbial flora associated with oral
carcinomas. Quintessence Int. 42:e118–e123. 2011.PubMed/NCBI
|
|
61
|
Karpiński TM: The microbiota and
pancreatic cancer. Gastroenterol Clin North Am. 48:447–464. 2019.
View Article : Google Scholar
|
|
62
|
Hettmann A, Demcsak A, Decsi G, Bach Á,
Pálinkó D, Rovó L, Nagy K, Takács M and Minarovits J: Infectious
agents associated with head and neck carcinomas. Adv Exp Med Biol.
897:63–80. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
63
|
Muto M, Hitomi Y, Ohtsu A, Shimada H,
Kashiwase Y, Sasaki H, Yoshida S and Esumi H: Acetaldehyde
production by non-pathogenic Neisseria in human oral
microflora: Implications for carcinogenesis in upper aerodigestive
tract. Int J Cancer. 88:342–350. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
64
|
Yokoi A, Ekuni D, Hata H, Yamane-Takeuchi
M, Maruyama T, Yamanaka R and Morita M: Relationship between
acetaldehyde concentration in mouth air and characteristics of
microbiota of tongue dorsum in Japanese healthy adults: A
cross-sectional study. J Appl Oral Sci. 27:e201806352019.
View Article : Google Scholar : PubMed/NCBI
|
|
65
|
Hooper SJ, Crean SJ, Fardy MJ, Lewis MAO,
Spratt DA, Wade WG and Wilson MJ: A molecular analysis of the
bacteria present within oral squamous cell carcinoma. J Med
Microbiol. 56:1651–1659. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
66
|
Vakevainen S, Tillonen J, Blom M,
Jousimies-Somer H and Salaspuro M: Acetaldehyde production and
other ADH-related characteristics of aerobic bacteria isolated from
hypochlorhydric human stomach. Alcohol Clin Exp Res. 25:421–426.
2001. View Article : Google Scholar : PubMed/NCBI
|
|
67
|
Meurman JH and Uittamo J: Oral
micro-organisms in the etiology of cancer. Acta Odontol Scand.
66:321–326. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
68
|
Abranches J, Zeng L, Kajfasz JK, Palmer
SR, Chakraborty B, Wen ZT, Richards VP, Brady LJ and Lemos JA:
Biology of oral Streptococci. Microbiol Spectr.
6:10.1128/microbiolspec.GPP3. 0042-2018. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
69
|
di Meo S, Reed TT, Venditti P and Victor
VM: Role of ROS and RNS sources in physiological and pathological
conditions. Oxid Med Cell Longev. 2016:12450492016. View Article : Google Scholar : PubMed/NCBI
|
|
70
|
Ikeda T, Kurita-Ochiai T, Takizawa T and
Hirasawa M: Isolation and characterization of the substance
isolated from Streptosporangium species which inhibits lactic acid
production by oral bacteria. Gen Pharmacol. 24:905–910. 1993.
View Article : Google Scholar : PubMed/NCBI
|
|
71
|
van Maanen JM, van Geel AA and Kleinjans
JC: Modulation of nitrate-nitrite conversion in the oral cavity.
Cancer Detect Prev. 20:590–596. 1996.PubMed/NCBI
|
|
72
|
Suzuki H, Iijima K, Scobie G, Fyfe V and
McColl KE: Nitrate and nitrosative chemistry within Barrett's
oesophagus during acid reflux. Gut. 54:1527–1535. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
73
|
Schett G, Elewaut D, McInnes IB, Dayer JM
and Neurath MF: How cytokine networks fuel inflammation: Toward a
cytokine-based disease taxonomy. Nat Med. 19:822–824. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
74
|
Jones SA, Scheller J and Rose-John S:
Therapeutic strategies for the clinical blockade of IL-6/gp130
signaling. J Clin Invest. 121:3375–3383. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
75
|
Neogi T: Clinical practice. Gout. N Engl J
Med. 364:443–452. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
76
|
Murata M: Inflammation and cancer. Environ
Health Prev Med. 23:502018. View Article : Google Scholar : PubMed/NCBI
|
|
77
|
Agassandian M and Shurin GV: Bacterial
infections and cancer development. Infection and cancer:
Bi-directorial interactions. 49–74. 2015.
|
|
78
|
Hoesel B and Schmid JA: The complexity of
NF-κB signaling in inflammation and cancer. Mol Cancer. 12:862013.
View Article : Google Scholar : PubMed/NCBI
|
|
79
|
Bradley JR: TNF-mediated inflammatory
disease. J Pathol. 214:149–160. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
80
|
Francescone R, Hou V and Grivennikov SI:
Microbiome, inflammation, and cancer. Cancer J. 20:181–189. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
81
|
Yan B, Wang H, Rabbani ZN, Zhao Y, Li W,
Yuan Y, Li F, Dewhirst MW and Li CY: Tumor necrosis factor-alpha is
a potent endogenous mutagen that promotes cellular transformation.
Cancer Res. 66:11565–11570. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
82
|
Sisk EA, Bradford CR, Jacob A, Yian CH,
Staton KM, Tang G, Harris MO, Carey TE, Lancaster WD and Gregoire
L: Human papillomavirus infection in ‘young’ versus ‘old’ patients
with squamous cell carcinoma of the head and neck. Head Neck.
22:649–657. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
83
|
Snider EJ, Freedberg DE and Abrams JA:
Potential role of the microbiome in Barrett's esophagus and
esophageal adenocarcinoma. Dig Dis Sci. 61:2217–2225. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
84
|
Moss SF and Blaser MJ: Mechanisms of
disease: Inflammation and the origins of cancer. Nat Clin Pract
Oncol. 2:90–97, 1, 113. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
85
|
Vogelmann R and Amieva MR: The role of
bacterial pathogens in cancer. Curr Opin Microbiol. 10:76–81. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
86
|
Cho TJ, Wee SW, Woo VH, Choi JI, Kim SJ,
Shin HI, Lee JH and Park HR: Porphyromonas
gingivalis-induced autophagy suppresses cell proliferation
through G1 arrest in oral cancer cells. Arch Oral Biol. 59:370–378.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
87
|
Li WQ, Ma JL, Zhang L, Brown LM, Li JY,
Shen L, Pan KF, Liu WD, Hu Y, Han ZX, et al: Effects of
Helicobacter pylori treatment on gastric cancer incidence
and mortality in subgroups. J Natl Cancer Inst. 106:dju1162014.
View Article : Google Scholar : PubMed/NCBI
|
|
88
|
Geng W and Zhang HY: Research on the
mechanism of HP mediated PI3K/AKT/GSK3β pathways in gastric cancer.
Eur Rev Med Pharmacol Sci. 21 (Suppl 3):S33–S37. 2017.
|
|
89
|
Xie Y and Liu L: Analysis of correlation
between HP infection and activation of PI3K/Akt pathway in mucosal
tissues of gastric cancer and precancerous lesions. Oncol Lett.
16:5615–5620. 2018.PubMed/NCBI
|
|
90
|
Zhang Y, Wang X, Li H, Ni C, Du Z and Yan
F: Human oral microbiota and its modulation for oral health. Biomed
Pharmacother. 99:883–893. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
91
|
Font-Burgada J, Sun B and Karin M: Obesity
and cancer: The oil that feeds the flame. Cell Metab. 23:48–62.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
92
|
Bao X, Chen F, Lin J, Chen Q, Chen L, Wang
R, Liu F, Wang J, Yan L, Lin L, et al: Association between dietary
inflammatory index and the risk of oral cancer in the southeast of
China. Eur J Clin Nutr. 74:938–944. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
93
|
Adler CJ, Malik R, Browne GV and Norris
JM: Diet may influence the oral microbiome composition in cats.
Microbiome. 4:232016. View Article : Google Scholar : PubMed/NCBI
|
|
94
|
Paul B, Barnes S, Demark-Wahnefried W,
Morrow C, Salvador C, Skibola C and Tollefsbol TO: Influences of
diet and the gut microbiome on epigenetic modulation in cancer and
other diseases. Clin Epigenetics. 7:1122015. View Article : Google Scholar : PubMed/NCBI
|
|
95
|
De Almeida CV, de Camargo MR, Russo E and
Amedei A: Role of diet and gut microbiota on colorectal cancer
immunomodulation. World J Gastroenterol. 25:151–162. 2019.
View Article : Google Scholar : PubMed/NCBI
|
|
96
|
Seidel DV, Azcarate-Peril MA, Chapkin RS
and Turner ND: Shaping functional gut microbiota using dietary
bioactives to reduce colon cancer risk. Semin Cancer Biol.
46:191–204. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
97
|
Bravi F, Bosetti C, Filomeno M, Levi F,
Garavello W, Galimberti S, Negri E and La Vecchia C: Foods,
nutrients and the risk of oral and pharyngeal cancer. Br J Cancer.
109:2904–2910. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
98
|
Klaenhammer TR, Kleerebezem M, Kopp MV and
Rescigno M: The impact of probiotics and prebiotics on the immune
system. Nat Rev Immunol. 12:728–734. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
99
|
Guarner F, Perdigon G, Corthier G,
Salminen S, Koletzko B and Morelli L: Should yoghurt cultures be
considered probiotic? Br J Nutr. 93:783–786. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
100
|
He L, Yang H, Tang J, Liu Z, Chen Y, Lu B,
He H, Tang S, Sun Y, Liu F, et al: Intestinal probiotics E.
coli Nissle 1917 as a targeted vehicle for delivery of p53 and
Tum-5 to solid tumors for cancer therapy. J Biol Eng. 13:582019.
View Article : Google Scholar : PubMed/NCBI
|
|
101
|
Jan G, Belzacq AS, Haouzi D, Rouault A,
Métivier D, Kroemer G and Brenner C: Propionibacteria induce
apoptosis of colorectal carcinoma cells via short-chain fatty acids
acting on mitochondria. Cell Death Diff. 9:179–188. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
102
|
Baldwin C, Millette M, Oth D, Ruiz MT,
Luquet FM and Lacroix M: Probiotic Lactobacillus acidophilus
and L. casei mix sensitize colorectal tumoral cells to
5-fluorouracil-induced apoptosis. Nutr Cancer. 62:371–378. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
103
|
Fotiadis CI, Stoidis CN, Spyropoulos BG
and Zografos ED: Role of probiotics, prebiotics and synbiotics in
chemoprevention for colorectal cancer. World J Gastroenterol.
14:6453–6457. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
104
|
Mima K, Nakagawa S, Sawayama H, Ishimoto
T, Imai K, Iwatsuki M, Hashimoto D, Baba Y, Yamashita YI, Yoshida
N, et al: The microbiome and hepatobiliary-pancreatic cancers.
Cancer Lett. 402:9–15. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
105
|
Gopalakrishnan V, Spencer CN, Nezi L,
Reuben A, Andrews MC, Karpinets TV, Prieto PA, Vicente D, Hoffman
K, Wei SC, et al: Gut microbiome modulates response to anti-PD-1
immunotherapy in melanoma patients. Science. 359:97–103. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
106
|
Zhou H, Suo J and Zhu J: Therapeutic
relevance of human microbiota and lung cancer. Zhongguo Fei Ai Za
Zhi. 22:464–469. 2019.(In Chinese). PubMed/NCBI
|
|
107
|
Catry E, Bindels LB, Tailleux A, Lestavel
S, Neyrinck AM, Goossens JF, Lobysheva I, Plovier H, Essaghir A,
Demoulin JB, et al: Targeting the gut microbiota with inulin-type
fructans: Preclinical demonstration of a novel approach in the
management of endothelial dysfunction. Gut. 67:271–283. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
108
|
Ambalam P, Raman M, Purama RK and Doble M:
Probiotics, prebiotics and colorectal cancer prevention. Best Pract
Res Clin Gastroenterol. 30:119–131. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
109
|
Raman M, Ambalam P, Kondepudi KK, Pithva
S, Kothari C, Patel AT, Purama RK, Dave JM and Vyas BR: Potential
of probiotics, prebiotics and synbiotics for management of
colorectal cancer. Gut Microbes. 4:181–192. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
110
|
Zheng C, Chen T, Wang Y, Gao Y, Kong Y,
Liu Z and Deng X: A randomised trial of probiotics to reduce
severity of physiological and microbial disorders induced by
partial gastrectomy for patients with gastric cancer. J Cancer.
10:568–576. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
111
|
Guglielmetti S, Taverniti V, Minuzzo M,
Arioli S, Stuknyte M, Karp M and Mora D: Oral bacteria as potential
probiotics for the pharyngeal mucosa. Appl Environ Microbiol.
76:3948–3958. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
112
|
Cortes-Dorantes N, Ruiz-Rodriguez MS,
Karakowsky-Kleiman L, Garrocho-Rangel JA, Sanchez-Vargas LO and
Pozos-Guillen AJ: Probiotics and their effect on oral bacteria
count in children: A pilot study. Eur J Paediatr Dent. 16:56–60.
2015.PubMed/NCBI
|
|
113
|
Nase L, Hatakka K, Savilahti E, Saxelin M,
Pönkä A, Poussa T, Korpela R and Meurman JH: Effect of long-term
consumption of a probiotic bacterium, Lactobacillus
rhamnosus GG, in milk on dental caries and caries risk in children.
Caries Res. 35:412–420. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
114
|
Krasse P, Carlsson B, Dahl C, Paulsson A,
Nilsson A and Sinkiewicz G: Decreased gum bleeding and reduced
gingivitis by the probiotic Lactobacillus reuteri. Swed Dent
J. 30:55–60. 2006.PubMed/NCBI
|
|
115
|
Xie H, Lu Q, Wang H, Zhu X and Guan Z:
Effects of probiotics combined with enteral nutrition on immune
function and inflammatory response in postoperative patients with
gastric cancer. J BUON. 23:678–683. 2018.PubMed/NCBI
|
|
116
|
Verhoog S, Taneri PE, Roa Díaz ZM,
Marques-Vidal P, Troup JP, Bally L, Franco OH, Glisic M and Muka T:
Dietary factors and modulation of bacteria strains of
Akkermansia muciniphila and Faecalibacterium
prausnitzii: A systematic review. Nutrients. 11:15652019.
View Article : Google Scholar : PubMed/NCBI
|
|
117
|
Chen XH, Wang A, Chu AN, Gong YH and Yuan
Y: Mucosa-associated microbiota in gastric cancer tissues compared
with non-cancer tissues. Front Microbiol. 10:12612019. View Article : Google Scholar : PubMed/NCBI
|
|
118
|
Clarridge JE III: Impact of 16S rRNA gene
sequence analysis for identification of bacteria on clinical
microbiology and infectious diseases. Clin Microbiol Rev.
17:840–862. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
119
|
Sanschagrin S and Yergeau E:
Next-generation sequencing of 16S ribosomal RNA gene amplicons. J
Vis Exp. 90:e517092014.PubMed/NCBI
|
|
120
|
Deo PN and Deshmukh R: Oral microbiome:
Unveiling the fundamentals. J Oral Maxillofac Pathol. 23:122–128.
2019.PubMed/NCBI
|
|
121
|
Pleguezuelos-Manzano C, Puschhof J,
Rosendahl Huber A, van Hoeck A, Wood HM, Nomburg J, Gurjao C,
Manders F, Dalmasso G, Stege PB, et al: Mutational signature in
colorectal cancer caused by genotoxic pks+ E.
coli. Nature. 580:269–273. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
122
|
Lavelle A and Sokol H: Gut microbiota:
Beyond metagenomics, metatranscriptomics illuminates microbiome
functionality in IBD. Nat Rev Gastroenterol Hepatol. 15:193–194.
2018. View Article : Google Scholar : PubMed/NCBI
|
|
123
|
Kleiner M, Thorson E, Sharp CE, Dong X,
Liu D, Li C and Strous M: Assessing species biomass contributions
in microbial communities via metaproteomics. Nat Commun.
8:15582017. View Article : Google Scholar : PubMed/NCBI
|
|
124
|
Miarons M, Roca M and Salvà F: The role of
pro-, pre- and symbiotics in cancer: A systematic review. J Clin
Pharm Ther. 46:50–65. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
125
|
Hu J, Han S, Chen Y and Ji Z: Variations
of tongue coating microbiota in patients with gastric cancer.
Biomed Res Int. 2015:1737292015. View Article : Google Scholar : PubMed/NCBI
|
|
126
|
Dong Z, Chen B, Pan H, Wang D, Liu M, Yang
Y, Zou M, Yang J, Xiao K, Zhao R, et al: Detection of microbial 16S
rRNA gene in the serum of patients with gastric cancer. Front
Oncol. 9:6082019. View Article : Google Scholar : PubMed/NCBI
|
|
127
|
Liu AQ and Chen W: Advances in esophageal
microbiota and esophageal related diseases. Zhonghua Zhong Liu Za
Zhi. 41:561–564. 2019.(In Chinese). PubMed/NCBI
|
